Recombinant Proteins

p53
LBP
CEA
HLA
TCL
TTC
NPM
MAF
Bax
BID

HPCAL1 Human

Hippocalcin-Like 1 Human Recombinant

HPCAL1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 213amino acids (1-193a.a.) and having a molecular wieght of 24.4kDa. The HPCAL1 is fused to 20a.a. His-Tag at N-terminus and purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT25805
Source
Escherichia Coli.
Appearance

Sterile filtered colorless solution.

VSNL1 Human

Visinin-Like Protein-1 Human Recombinant

VSNL1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 191 amino acids (1-191 a.a.) and having a molecular mass of 22.1kDa.
The VSNL1 is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT25883
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless solution.

VSNL1 Human, His

Visinin-Like Protein-1 Human Recombinant, His Tag

Visinin-Like Protein-1 Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 201 amino acids and having a molecular mass of 23.4 kDa.
Visinin-Like Protein-1 is fused to His tag at N-Terminus.
The protein‘s amino acid sequence corrssponds toUniProtKB/Swiss-Prot entry P62760.
Visinin-Like Protein-1 is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT25977
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Definition and Classification

Visinin-like proteins (VSNLs) are a subfamily of neuronal calcium sensor (NCS) proteins. These proteins are homologous to visinin, a protein originally identified in the retina. The VSNL subfamily includes VILIP-1 (the founder protein), VILIP-2, VILIP-3, hippocalcin, and neurocalcin δ . These proteins are characterized by their ability to bind calcium ions and play crucial roles in calcium signaling pathways.

Biological Properties

Key Biological Properties: VSNLs are calcium-binding proteins that undergo a calcium-myristoyl switch mechanism, allowing them to translocate to cellular membranes in response to calcium binding . They have distinct calcium affinities and membrane-binding kinetics.

Expression Patterns and Tissue Distribution: VSNLs are predominantly expressed in the brain, with restricted expression patterns in various subsets of neurons . For example, VILIP-1 is strongly expressed in granule cells of the cerebellum . Additionally, VILIP-1 has been detected in peripheral organs such as the heart, liver, lung, and testis .

Biological Functions

Primary Biological Functions: VSNLs modulate intracellular signaling pathways by regulating the activity of adenylyl cyclase and other targets . They play roles in cyclic nucleotide and MAPK signaling, gene expression, and membrane trafficking .

Role in Immune Responses and Pathogen Recognition: While the primary focus of VSNLs is on neuronal functions, emerging research suggests potential roles in immune responses and pathogen recognition, although this area requires further investigation .

Modes of Action

Mechanisms with Other Molecules and Cells: VSNLs interact with various intracellular targets after calcium binding. They modulate cellular signal transduction pathways, including cyclic nucleotide and MAPK signaling .

Binding Partners and Downstream Signaling Cascades: VSNLs interact with components of membrane trafficking complexes, affecting the trafficking of receptors and ion channels such as glutamate receptors and nicotinic acetylcholine receptors . These interactions influence neuronal signaling and differentiation.

Regulatory Mechanisms

Regulatory Mechanisms Controlling Expression and Activity: The expression and activity of VSNLs are regulated at multiple levels, including transcriptional regulation and post-translational modifications . For instance, VILIP-1 expression is down-regulated in Alzheimer’s disease, correlating with the presence of neurofibrillary tangles and amyloid plaques .

Transcriptional Regulation and Post-Translational Modifications: Specific transcription factors and signaling pathways regulate the transcription of VSNL genes. Post-translational modifications, such as phosphorylation, also play a role in modulating their activity .

Applications

Biomedical Research: VSNLs are valuable tools in studying calcium signaling and neuronal function. They are used to investigate the mechanisms underlying neurodegenerative diseases and other neurological disorders .

Diagnostic Tools: VILIP-1 has emerged as a potential biomarker for neuronal injury and neurodegenerative diseases such as Alzheimer’s disease . Elevated levels of VILIP-1 in cerebrospinal fluid and serum have been associated with cognitive decline and disease progression .

Therapeutic Strategies: Targeting VSNLs and their signaling pathways holds promise for developing therapeutic strategies for neurodegenerative diseases and other conditions involving calcium dysregulation .

Role in the Life Cycle

Role Throughout the Life Cycle: VSNLs play crucial roles in neuronal development, differentiation, and function. They are involved in processes such as synaptic plasticity, memory formation, and neuroprotection . Dysregulation of VSNLs has been implicated in aging and age-related diseases, including Alzheimer’s disease .

© Copyright 2024 Thebiotek. All Rights Reserved.